CG Oncology, Inc. (CGON)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Biotechnology	1.14M	204.00K	191.00K	10.36M
Biotechnology Growth	458.33%	6.81%	-98.16%	-
Total	1.14M	204.00K	191.00K	10.36M
Total Growth	458.33%	6.81%	-98.16%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	1.14M	204.00K	191.00K	10.36M
United States Growth	458.33%	6.81%	-98.16%	-
Total	1.14M	204.00K	191.00K	10.36M
Total Growth	458.33%	6.81%	-98.16%	-

Source: S&P Global Market Intelligence.